Dudediligence.

Vistagen Therapeutics, Inc

VTGNNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

44.4M

on 2026-08-10, from 27.0M on 2024-06-07 10-Q ↗

10M20M30M40MJun2024AugNovFeb2025JunAugNovFeb2026JunAug

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

$175.0M

Agreement of 2025-06-17. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

20.56M

Warrants of every class as tagged in the XBRL facts on 2026-06-30, exercise price $7.30. 10-Q ↗

Cash

2 quarters

$31.7M on 2026-06-30 ÷ $15.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 1 of its filings are not read yet.